Bangladesh Pharmaceuticals Market & It's Future (for non pharma background) if you need the slide please call +8801717678894 or email: shadhin1008@live.com

1. Presented by:
Md.Golam Kibria
A.S.M. Faruk Hossain
EMBA Program
Date: 28th April 2018
Saturday, April 28, 2018 1EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
Bangladesh Pharmaceutical
Market & it’s future

2. INTRODUCTION
Pharmaceutical sector is one of the most
promising sectors in Bangladesh.
With this presentation, we want to go through a
visual journey to our pharmaceutical market and
its future.
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
2

3. WHAT IS PHARMACY
Pharmacy is a science that deals with the
process of turning a new chemical entity or old
drugs into a medication to be used safely and
effectively.
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
3

4. SYMBOL
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
4
Hygieia was the Greek goddess of hygiene, and the
daughter of Asclepius.
Asclepius' symbol is his rod, with a snake twined
around it; correspondingly,
Hygieia's symbol is a cup with a snake twined around
its stem and poised above it.
Bowl of Hygieia

5. PHARMACEUTICAL INDUSTRY
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
5
The pharmaceutical industry discovers, develops,
produces, and markets drugs or
pharmaceutical drugs for use as
medications. Pharmaceutical companies may deal
in generic or brand medications and medical
devices.

6. HOW PHARMACEUTICAL INDUSTRY
WORKS
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
6
Drug
Discovery
Drug
Designing
Animal Test Manufacturing
Marketing

7. WHAT IS PHARMACEUTICAL
MARKETING
Pharmaceutical marketing is based on “Below the line
“marketing strategy where they are not focusing on
direct user instead they target the doctors.
Generally pharma companies use following tools as
their marketing strategy;
Scientific data (Product Literature)
Product related Give-away CME’s or Conferences like
ASCO,ESMO,ELCC,SFO
Product Samples
Gifts, Wishes
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
7

8. TOP 10 GLOBAL PHARMACEUTICAL
COMPANIES BASED ON PHARMA REVENUE IN
2017 (IN MILLION U.S. DOLLARS)
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
8

9. BANGLADESH PHARMA INDUSTRY
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
9

10. PRE-LIBERATION/LIBERATION
PERIOD:
Before Liberation, there was hardly any pharmaceutical
enterprise in Bangladesh (then East Pakistan).
After several years of liberation, the government could
not increase (in relative terms) budgetary allocations
for the improvement of health sector.
This sector started to improve from 1980s.
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
10

11. DRUGS (CONTROL) ORDINANCE,
1982
Without “A” grade pharmacists, no Manufacturing.
No advertisement without the prior approval of the
licensing authority.
cGMP
Penalty for un-authorised import of drugs.
Penalty for manufacture or sale of sub-standard drugs.
Review of certain licensing agreement with foreign
concerns.
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
11

12. CURRENT STATUS
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
12
ALLOPATHIC
Manufacturer:
257
Registered Drugs:
28,508
Total Generic:
3,534
Retail Pharmacy:
107,446
AYURVEDIC
Manufacturer: 201
Registered Drugs:
3,899
Retail Pharmacy: 367
HARBAL
Manufacturer: 451
Manufacturer: 32
Retail Pharmacy: 10
HOMEOPATHIC
Manufacturer: 42
Registered Drugs:
2,313
Retail Pharmacy: 2,152
UNANI
Manufacturer: 272
Total Registered Drugs:
5,771
Retail Pharmacy: 642
Source: Directorate General of Drug Administration

13. MAJOR PHARMA COMPANIES OF
BANGLADESH
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
13
Square Pharmaceuticals Ltd. Opsonin Pharma Ltd.
Beximco Pharmaceuticals Ltd. Ziska Pharma
Incepta Pharmaceutical Ltd. Jayson Pharmaceuticals Ltd.
Renata Limited Drug International Limited.
ACI Limited Beacon Pharmaceuticals
ACME Laboratories Ltd. Popular Pharmaceuticals
Aristopharma Ltd. Eskayef Bangladesh Ltd.
General Pharmaceutical Ltd. GlaxoSmithKline Bangladesh Limited
Globe Pharmaceuticals Ltd. Sanofi Aventis
Healthcare Pharmaceuticals Limited Nuvista Pharma Ltd.
Bio-Pharma Laboratories Ltd. Zuellig Pharma Bangladesh Ltd.
Novartis (Bangladesh) Ltd. Novo Nordisk

14. MARKET SIZE
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
14
130,952,182,317
177,143,987,607
196,288,818,719
0
50,000,000,000
100,000,000,000
150,000,000,000
200,000,000,000
250,000,000,000
2015 2016 2017
IMS HEALTH
13k
Cr.
Taka
17k
Cr.
Taka
20k
Cr.
Taka

15. TOP 10 BRANDS
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
15
0
500,000,000
1,000,000,000
1,500,000,000
2,000,000,000
2,500,000,000
3,000,000,000
3,500,000,000
4,000,000,000
2015 2016 2017

16. EXPORT FROM BANGLADESH (CR)
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
16
179.52
134.41
112.6
92.62
74.69
64.56
55.34 49.47 45.44
24.34 22.35 18.53 16.92 16 13.96 11.37
119.88
July16-July 17
DGDA

17. Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
17
Sl Company
July 16-June 17 % of
Market Share
BDT (in CR.)
1 Beximco 179.52 17.1
2 Square 134.41 12.8
3 Incepta 112.6 10.7
4 Beacon 92.62 8.8
5 Novertis 74.69 7.1
6 Nipro-JMI 64.56 6.1
7 Renata 55.34 5.3
8 ARISTO 49.47 4.7
9 ACME 45.44 4.3
10 SK+F 24.34 2.3
11 Orion 22.35 2.1
12 Globe 18.53 1.8
13 Delta 16.92 1.6
14 Global Cap. 16 1.5
15 Health Care 13.96 1.3
16 Popular 11.37 1.0
17 Others 119.88 11.4
Total 1052

18. INDUSTRY FUTURE
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
18

19. OPPORTUNITIES IN GLOBAL
GENERIC DRUGS & BANGLADESH
IS AN EMERGING GENERIC HUB IN
ASIA
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
19
Global generics market is valued at
around US $1.06 trillion and is
projected to grow $1.30 trillion by
2020
Bangladesh offers tremendous
manufacturing cost advantages
Major generic hubs India and China
are losing cost advantages
Extended patent waiver from TRIPS

20. ADVANTAGES OF TRIPS
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
20
Bangladesh and other
LDCs are exempted from
patent protection by
WTO for an extended
period until 2033 (from
original 2016).
That means we can
manufacture any
patented or non patented
drug till 2033

21. API PARK
Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
21
Firstly, producing the API locally will decrease
the cost of locally manufactured drugs and it
will add to the cost advantage for exports.
Secondly, API can themselves be exported to
countries and compared to drug products, API
are easier to export. Global API market stands
at 135 billion USD.

22. Saturday, April 28, 2018 EXECUTIVE MASTERS OF BUSINESS ADMINISTRATION, UNIVERSITY OF LIBARAL ARTS
BANGLADESH
22
Regards,
Faruk Hossain, Sr. Executive, Global
Marketing, Beacon Medicare Limited
+88 01717678894
shadhin1008@live.com
ULAB EMBA STUDENT
https://www.linkedin.com/in/farukhossa
in1008